18375896

Source:http://linkedlifedata.com/resource/pubmed/id/18375896

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0014912, umls-concept:C0014942, umls-concept:C0032105, umls-concept:C0043210, umls-concept:C0232970, umls-concept:C0246421, umls-concept:C0290883
pubmed:issue	10
pubmed:dateCreated	2008-3-31
pubmed:abstractText	To compare the effects of anastrozole and letrozole on plasma estradiol (E2) and estrone sulfate (E1S) levels.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrone, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Selective Estrogen Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Triazoles, http://linkedlifedata.com/resource/pubmed/chemical/anastrozole, http://linkedlifedata.com/resource/pubmed/chemical/estrone sulfate, http://linkedlifedata.com/resource/pubmed/chemical/letrozole
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1527-7755
pubmed:author	pubmed-author:A'HernRoger PRP, pubmed-author:CameronDavid ADA, pubmed-author:DixonJ MichaelJM, pubmed-author:DowsettMitchM, pubmed-author:FolkerdElizabethE, pubmed-author:MacaskillE JaneEJ, pubmed-author:McHughMaryM, pubmed-author:MurrayJulietteJ, pubmed-author:RenshawLornaL, pubmed-author:YoungOliverO
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1671-6
pubmed:meshHeading	pubmed-meshheading:18375896-Adult, pubmed-meshheading:18375896-Aged, pubmed-meshheading:18375896-Aged, 80 and over, pubmed-meshheading:18375896-Antineoplastic Agents, pubmed-meshheading:18375896-Breast Neoplasms, pubmed-meshheading:18375896-Chemotherapy, Adjuvant, pubmed-meshheading:18375896-Cross-Over Studies, pubmed-meshheading:18375896-Estradiol, pubmed-meshheading:18375896-Estrone, pubmed-meshheading:18375896-Female, pubmed-meshheading:18375896-Humans, pubmed-meshheading:18375896-Middle Aged, pubmed-meshheading:18375896-Nitriles, pubmed-meshheading:18375896-Postmenopause, pubmed-meshheading:18375896-Radioimmunoassay, pubmed-meshheading:18375896-Selective Estrogen Receptor Modulators, pubmed-meshheading:18375896-Tamoxifen, pubmed-meshheading:18375896-Treatment Outcome, pubmed-meshheading:18375896-Triazoles
pubmed:year	2008
pubmed:articleTitle	Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
pubmed:affiliation	Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom. jmd@ed.ac.uk
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Multicenter Study